C07K 5/126
Tetrapeptides
Official title: {Tetrapeptides}
C07K5/126 (Tetrapeptides) appears on 91 US grants and 111 published applications in this corpus.
Search patents in C07K- Granted patents
- 91
- Published applications
- 111
- Assignees
- 84
- Inventors
- 295
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 4 | 2 |
| 2003 | 2 | 4 |
| 2004 | 3 | 2 |
| 2005 | 2 | 5 |
| 2006 | 1 | 3 |
| 2007 | 2 | 3 |
| 2008 | 0 | 4 |
| 2009 | 2 | 4 |
| 2010 | 1 | 2 |
| 2011 | 2 | 4 |
| 2012 | 3 | 5 |
| 2013 | 4 | 7 |
| 2014 | 3 | 3 |
| 2015 | 4 | 3 |
| 2016 | 5 | 7 |
| 2017 | 3 | 9 |
| 2018 | 4 | 7 |
| 2019 | 5 | 4 |
| 2020 | 4 | 8 |
| 2021 | 4 | 9 |
| 2022 | 3 | 3 |
| 2023 | 6 | 4 |
| 2024 | 3 | 4 |
| 2025 | 0 | 1 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds and methods for treating cancer, viral infections, and allergic conditions31 Mar 2026US 12,590,123 B2Washington University
- Macrocyclic modulators of disease associated protein misfolding and aggregation24 Feb 2026US 12,559,863 B2Resq Biotech
- Cyclic peptides multimers targeting α4β7 integrin3 Sep 2024US 12,077,611 B2Zealand Pharma A/S
- Proteasome inhibitors4 Jun 2024US 11,999,803 B2University of Kentucky Research Foundation
- Macrocyclic modulators of disease associated protein misfolding and aggregation2 Jan 2024US 11,858,974 B2Resq Biotech
- Methods of synthesizing fluorinated macrocycles27 Aug 2026US 2026/0250321 A1The Regents of the University of California
- Macrocyclic modulators of disease associated protein misfolding and aggregation6 Aug 2026US 2026/0226658 A1Resq Biotech
- Heterodimer and radioactive medical use thereof26 Feb 2026US 2026/0053961 A1Hexin (Suzhou) Pharmaceutical Technology Co., Ltd.
- Compositions and methods for dye-bound cyclized peptides for medical use12 Feb 2026US 2026/0042801 A1The Texas A&M University System
- De novo designed macrocyclic oligoamides3 Apr 2025US 2025/0111889 A1University of Washington
Most cited
By later US patents
- Histone deacetylases, and uses related thereto116US 6,777,217 B1President and Fellows of Harvard College · 2004
- Conformationally restricted biologically active peptides, methods for their production and uses thereof89US 5,364,851 AInternational Synthecon, LLC · 1994
- Pretargeting methods and compounds47US 5,541,287 ANeoRx Corporation · 1996
- Histone deacetylases, and uses related thereto40US 7,994,362 B2President and Fellows of Harvard College · 2011
- Modulation of hepatitis B virus CCCDNA transcription32US 9,623,071 B2Baruch S. Blumberg Institute · 2017